- Filed
- Dec 2, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Nov 21, 2025 | 1.11B sh |
| Shares Diluted | Q3 2026 · Nov 1, 2025 | 1.13B sh |
| Shares Diluted | Q3 2026 · Nov 1, 2025 | 1.13B sh |
| Shares Diluted | Q3 2026 · Nov 2, 2024 | 1.14B sh |
| Shares Diluted | Q3 2026 · Nov 2, 2024 | 1.14B sh |
| Stock Repurchased | Q3 2026 · Nov 1, 2025 | $1.74B |
| Stock Repurchased | Q3 2026 · Nov 2, 2024 | $1.66B |
| Dividends Paid | Q3 2026 · Nov 1, 2025 | $1.37B |
| Dividends Paid | Q3 2026 · Nov 2, 2024 | $1.23B |
| Capex | Q3 2026 · Nov 1, 2025 | $1.49B |
| Capex | Q3 2026 · Nov 2, 2024 | $1.4B |
| Operating Cash Flow | Q3 2026 · Nov 1, 2025 | $3.72B |
| Operating Cash Flow | Q3 2026 · Nov 2, 2024 | $3.41B |
| Long Term Debt | Q3 2026 · Nov 1, 2025 | $1.87B |
| Long Term Debt | Q3 2026 · Feb 1, 2025 | $2.87B |
| Long Term Debt | Q3 2026 · Nov 2, 2024 | $2.87B |
| Cash And Equivalents | Q3 2026 · Nov 1, 2025 | $4.64B |
| Cash And Equivalents | Q3 2026 · Feb 1, 2025 | $5.34B |
| Cash And Equivalents | Q3 2026 · Nov 2, 2024 | $4.72B |
| Stockholders Equity | Q3 2026 · Nov 1, 2025 | $9.36B |
| Stockholders Equity | Q3 2026 · Aug 2, 2025 | $8.87B |
| Stockholders Equity | Q3 2026 · Feb 1, 2025 | $8.39B |
| Stockholders Equity | Q3 2026 · Nov 2, 2024 | $8.17B |
| Stockholders Equity | Q3 2026 · Aug 3, 2024 | $7.78B |
| Stockholders Equity | Q3 2026 · Feb 3, 2024 | $7.3B |
| Current Liabilities | Q3 2026 · Nov 1, 2025 | $14B |
| Current Liabilities | Q3 2026 · Feb 1, 2025 | $11.01B |
| Current Liabilities | Q3 2026 · Nov 2, 2024 | $12.02B |
| Current Assets | Q3 2026 · Nov 1, 2025 | $15.31B |
| Current Assets | Q3 2026 · Feb 1, 2025 | $12.99B |
| Current Assets | Q3 2026 · Nov 2, 2024 | $14.35B |
| Total Assets | Q3 2026 · Nov 1, 2025 | $35.19B |
| Total Assets | Q3 2026 · Feb 1, 2025 | $31.75B |
| Total Assets | Q3 2026 · Nov 2, 2024 | $32.44B |
| Eps Diluted | Q3 2026 · Nov 1, 2025 | $1.28 |
| Eps Diluted | Q3 2026 · Nov 1, 2025 | $3.30 |
| Eps Diluted | Q3 2026 · Nov 2, 2024 | $1.14 |
| Eps Diluted | Q3 2026 · Nov 2, 2024 | $3.03 |
| Eps Basic | Q3 2026 · Nov 1, 2025 | $1.30 |
| Eps Basic | Q3 2026 · Nov 1, 2025 | $3.34 |
| Eps Basic | Q3 2026 · Nov 2, 2024 | $1.15 |
| Eps Basic | Q3 2026 · Nov 2, 2024 | $3.07 |
| Sga Expense | Q3 2026 · Nov 1, 2025 | $3.04B |
| Sga Expense | Q3 2026 · Nov 1, 2025 | $8.39B |
| Sga Expense | Q3 2026 · Nov 2, 2024 | $2.75B |
| Sga Expense | Q3 2026 · Nov 2, 2024 | $7.81B |
| Net Income | Q3 2026 · Nov 1, 2025 | $1.44B |
| Net Income | Q3 2026 · Nov 1, 2025 | $3.72B |
| Net Income | Q3 2026 · Nov 2, 2024 | $1.3B |
| Net Income | Q3 2026 · Nov 2, 2024 | $3.47B |
| Cost Of Revenue | Q3 2026 · Nov 1, 2025 | $10.19B |
| Cost Of Revenue | Q3 2026 · Nov 1, 2025 | $29.41B |
| Cost Of Revenue | Q3 2026 · Nov 2, 2024 | $9.62B |
| Cost Of Revenue | Q3 2026 · Nov 2, 2024 | $27.74B |